News

Zalgen Immunotherapeutic Confers Complete Protection Against Advanced Multilineage Lassa Infections in Nonhuman Primates

Article in Proceedings of the National Academy of Sciences (PNAS) reports data from the latest study at the University of Texas Medical Branch at Galveston (UTMB) showing protection against Lassa Fever, a significant threat to global health. FREDERICK, Md., Aug. 18, 2023 /PRNewswire/ — Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases, including Lassa Fever (LF), today announced publication […]

Zalgen Immunotherapeutic Confers Complete Protection Against Advanced Multilineage Lassa Infections in Nonhuman Primates Read More »

Zalgen Relocates Headquarters to Life Sciences Epicenter in Frederick, Maryland

Frederick, MD, December 16, 2021 – One of the leading biotechnology and diagnostics companies in the field of neglected viral diseases with pandemic potential now calls a prime biotechnology and life sciences community its home, as Zalgen Labs LLC today announced its headquarters has relocated to Frederick, Maryland. Preparedness is Zalgen’s mantra. Founded on the concept of

Zalgen Relocates Headquarters to Life Sciences Epicenter in Frederick, Maryland Read More »

Shopping Cart
Scroll to Top